Esperion Therapeutics, Inc. (ESPR)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$1.90
-0.26%
Mkt Cap $397.11M
Next Earnings
In 7 daysTue, May 5, 2026
EPS Estimate
-$0.04
3 analysts
Revenue Estimate
$94.87M
Last quarter: missed by -4.35% on EPS, +1.20% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$397.11M
P/E
—
Fwd P/E
25.11
P/S
0.99
Rev TTM
—
EPS TTM
-$0.17